Setz, C.; Große, M.; Auth, J.; Fröba, M.; Rauch, P.; Bausch, A.; Wright, M.; Schubert, U.
Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern. Int. J. Mol. Sci. 2022, 23, 6830.
https://doi.org/10.3390/ijms23126830
AMA Style
Setz C, Große M, Auth J, Fröba M, Rauch P, Bausch A, Wright M, Schubert U.
Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern. International Journal of Molecular Sciences. 2022; 23(12):6830.
https://doi.org/10.3390/ijms23126830
Chicago/Turabian Style
Setz, Christian, Maximilian Große, Janina Auth, Maria Fröba, Pia Rauch, Alexander Bausch, Matthew Wright, and Ulrich Schubert.
2022. "Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern" International Journal of Molecular Sciences 23, no. 12: 6830.
https://doi.org/10.3390/ijms23126830
APA Style
Setz, C., Große, M., Auth, J., Fröba, M., Rauch, P., Bausch, A., Wright, M., & Schubert, U.
(2022). Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern. International Journal of Molecular Sciences, 23(12), 6830.
https://doi.org/10.3390/ijms23126830